慢性肢体威胁性缺血长段股腘病变:腔内治疗与旁路手术长期结局比较
中位随访61个月,PTA/S组再干预率显著更高(44.68% vs 29.79%,p=.002),但大截肢率无显著差异(27.23% vs 22.13%,p=.17);OSB组总体并发症率显著更高(20.42% vs 5.96%,p<.001)。
要点
- GLASS III-IV级股腘病变CLTI中,OSB长期再干预率低于PTA/S,但术后并发症更多。
- 两组大截肢率无显著差异(PTA/S 27.23% vs OSB 22.13%,p=.17)。
- OSB组总体并发症率20.42% vs PTA/S 5.96%(p<.001),伤口感染/血清肿需延长住院进一步治疗者7.65% vs 0%。
核心结论
- 对于CLTI合并GLASS III-IV级股腘病变,旁路手术在长期再干预率方面似乎优于PTA/S,但术后并发症率显著更高。
研究设计与样本
- 采用基线与血管造影协变量计算倾向评分,匹配后PTA/S组与OSB组各235条肢体进入分析。
- 主要结局为患肢免于再干预和大截肢,次要结局为两组所有住院并发症。
主要发现
- OSB组总体并发症率显著高于PTA/S组(20.42% vs 5.96%,p<.001)。
- OSB组需延长住院和进一步治疗的伤口感染/血清肿率为7.65%,PTA/S组为0%(p<.001)。
- 中位随访61个月,PTA/S组再干预率显著高于OSB组(44.68% vs 29.79%,p=.002)。
- 两组大截肢率无显著差异(PTA/S 27.23% vs OSB 22.13%,p=.17)。
关键数值与推荐
- 再干预率:PTA/S 44.68% vs OSB 29.79%(log rank检验,p=.002)。
- 大截肢率:PTA/S 27.23% vs OSB 22.13%(log rank检验,p=.17)。
- 总体并发症率:OSB 20.42% vs PTA/S 5.96%(p<.001)。
- 伤口感染/血清肿需延长住院进一步治疗:OSB 7.65% vs PTA/S 0%(p<.001)。
临床怎么用
- 在GLASS III-IV级股腘病变CLTI患者选择血运重建方式时,需权衡OSB更低的长期再干预率与更高的围手术期并发症风险。
- 对于高手术并发症风险患者,PTA/S虽再干预率较高但围手术期并发症显著更少,可作为个体化选择。
局限性
- 本研究为回顾性两中心设计,结论需正在进行的随机试验及前瞻性队列研究进一步证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: There are currently two treatments available for patients with chronic limb threatening ischaemia (CLTI): open surgical bypass (OSB) and percutaneous transluminal angioplasty with/without stenting (PTA/S). The aim of this study was to compare short and long term outcomes between PTA/S and OSB in CLTI patients with long (GLASS grade III and IV) femoropopliteal disease. METHODS: This was a two centre retrospective study including all consecutive patients with CLTI undergoing first time lower extremity intervention at two distinct vascular surgical centres. Between 1 January 2012 and 1 January 2018, 1 545 CLTI consecutive limbs were treated for femoropopliteal GLASS grade III and IV lesions at two vascular surgical centres. Using covariables from baseline and angiographic characteristics, a propensity score was calculated for each limb. Thus, comparable patient cohorts (235 in PTA/S and 235 in OSB group) were identified for further analysis. The primary outcomes were freedom from re-intervention in the treated extremity and major amputation. Secondary outcomes were all hospital complications among the two patient groups. RESULTS: Total overall complication rates were significantly higher in the OSB group (20.42% vs. 5.96%, p < .001), especially wound infection/seroma rate that required prolonged hospitalisation and further treatment (7.65% vs. 0%, p < .001). After the median follow up of 61 months, re-intervention rates were significantly higher in the PTA/S group (log rank test, 44.68% vs. 29.79%, p = .002), but there was no significant difference in terms of major amputation rates between the two group of patients (log rank test, PTA/S 27.23% vs. OSB 22.13%, p = .17). CONCLUSION: Bypass surgery seems to be superior to PTA/S for GLASS grade III and IV femoropopliteal lesions in patients with CLTI in terms of long term re-intervention rates, but with considerably higher rates of post-operative complications. A larger cohort of patients in currently ongoing randomised trials, as well as prospective cohort studies are necessary to confirm these findings.
引用
- Zlatanovic P, Mahmoud AA, Cinara I, et al. Comparison of Long Term Outcomes After Endovascular Treatment Versus Bypass Surgery in Chronic Limb Threatening Ischaemia Patients with Long Femoropopliteal Lesions. Eur J Vasc Endovasc Surg. 2020. PMID: 33334672. doi:10.1016/j.ejvs.2020.11.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。